BeyondSpring BYSI
NASDAQ BYSI
$0.46 -0.04 (-7.08%)
As of: Oct 22, 2026 · 1:15 PM EDT

BeyondSpring (BYSI) EBIT Margin (2020 - 2021)

Updated

BeyondSpring (BYSI) recorded EBIT Margin of -2756.40% in FY2022, up 2146.63 percentage points from -4903.03% in FY2021.

Analysis

BeyondSpring (BYSI) EBIT Margin (2020 - 2021) Analysis & Trends

  • Per Business Quant data, BYSI's EBIT Margin was -4903.03% in FY2021 (+30769.74 pp) and -35672.78% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn 24.35%
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn 37.86%
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn -3.52%
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn 20.57%
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn -133.21%
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 28.37%
10 BeyondSpring 18.95 Mn 12.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -3,104.14%
Sep 30, 2021 -5,444.81%
Jun 30, 2021 -5,910.95%
Mar 31, 2021 -5,153.85%
Dec 31, 2020 -10,341.67%
API Access

BeyondSpring EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=BYSI&period=max&api_key=YOUR_API_KEY